Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

broussoflavonol B

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Flavonols

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Broussoflavonol B from Broussonetia kazinoki Siebold Exerts Anti-Pancreatic Cancer Activity through Downregulating FoxM1
Pancreatic cancer has a high mortality rate due to poor rates of early diagnosis. One tumor suppressor gene in particular, p53… Expand
  • figure 2
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen.
Tamoxifen provided a successful treatment for ER-positive breast cancer for many years. However, HER2 overexpressing breast… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
Tamoxifen provided a successful treatment for ER-positive breast cancer for many years. However, most breast tumors develop… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells.
Estrogen receptor (ER)-negative breast cancers are aggressive and unresponsive to antiestrogens, and current therapeutic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
Broussoflavonol B restricts growth of ER-negative breast cancer stem-like cells.
Accumulating experimental and clinical evidence has indicated that tumor-initiating or cancer stem-like cells are a sub… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE